Caris Life Sciences, Inc.'s total assets for Q3 2025 were $984.57M, an increase of 3.09% from the previous quarter. CAI total liabilities were $506.21M for the fiscal quarter, a 0.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.